Experiment 1158088

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationDE VRIES,EGE: MULDER,NH: POSTMUS,PE: VRIESENDORP,R: WILLEMSE,PHB: SLEIJFER,DT:. (1986). HIGH-DOSE TENIPOSIDE FOR REFRACTORY MALIGNANCIES: A PHASE I STUDY.. 70(5)
Amount utilized
Compound isolated
DiseaseIN THIS PHASE I STUDY,18 PATIENTS WITH REFRACTORY DISSEMINATED MALIGNANCIES WERE EVALUATED,TENIPOSIDE WAS GIVEN ON 3 CONSECUTIVE DAYS WITH AN INITIAL DOSE PER COURSE OF 0.3 G/SQ.M. WITH ESCALATIONS TO 0.6 TO 1 G/SQ.M. IN THE 13 PATIENTS EVALUABLE FOR RESPONSE, THERE WERE 5 PARTIAL REMISSIONS,1 MINOR RESPONSE AND 4 STABLE DISEASE. ALL 3 PATIENTS IN THE HIGHEST DOSE GROUP DEVELOPED SEVERE SKIN RASH. LEUKOPENIA AND THROMBOCYTOPENIA WERE DOSE DEPENDENT. A DOSE OF 0.6 G/SQ.M. IS RECOMMENDED FOR PHASE II STUDIES.
Dose amountVAR
Number1
Qualitative resultEQUIVOCAL
AnimalHUMAN ADULT
Dose expressionDOSE